Short Interest in HCW Biologics Inc. (NASDAQ:HCWB) Grows By 905.4%

HCW Biologics Inc. (NASDAQ:HCWB) was the recipient of a large growth in short interest in February. As of February 15th, there was short interest totalling 835,500 shares, a growth of 905.4% from the January 31st total of 83,100 shares. Approximately 3.6% of the company’s stock are sold short. Based on an average trading volume of 6,100,000 shares, the short-interest ratio is presently 0.1 days.

HCW Biologics Stock Performance

Shares of NASDAQ:HCWB opened at $0.38 on Friday. HCW Biologics has a 52-week low of $0.21 and a 52-week high of $2.52. The firm has a market capitalization of $16.93 million, a P/E ratio of -0.38 and a beta of 0.81. The stock has a 50 day moving average price of $0.39 and a 200-day moving average price of $0.47.

About HCW Biologics

HCW Biologics Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.